Overview
BenevolentAI develops a next-generation platform dedicated to intelligence in life sciences. The company recognises that every data point holds the potential for major discoveries. The platform targets the complex decisions that structure research and development, by making scientific intelligence available to teams. BenevolentAI brings together cross-functional teams in science and technology, pushing the boundaries of AI and machine learning. Built on a decade of investment in its proprietary graph knowledge base and ontologies, the company supports scientists and executives in confidently and accurately leveraging cutting-edge AI.
Services and expertise
Life sciences intelligence platform
BenevolentAI's platform addresses critical decision-making challenges in pharmaceutical research and development. It transforms data into actionable scientific intelligence, enabling R&D teams to access structured and reliable scientific intelligence to guide their research strategies.
Artificial intelligence and machine learning
BenevolentAI integrates AI and machine learning into scientific processes, drawing on a graph knowledge base developed over ten years of investment. The solutions offered provide precision and confidence suited to pharmaceutical and biomedical innovation contexts.
Proprietary ontologies and knowledge base
BenevolentAI's technical infrastructure is built on proprietary ontologies and a sophisticated knowledge base. These foundational elements structure the platform's artificial intelligence, guaranteeing the quality and relevance of the intelligence generated for users.
Philosophy
BenevolentAI builds technology in service of science. This orientation places the support of scientists and executives at the heart of the approach, prioritising trust and precision in applying AI to concrete scientific challenges.
https://www.benevolent.com
